Abstract:Abstract Background Under physiological conditions, CXCL12 modulates cell proliferation, survival, angiogenesis, and migration mainly through CXCR4. Interestingly, the newly discovered receptor CXCR7 for CXCL12 is highly expressed in many tumor cells as well as tumor-associated blood vessels, although the level of CXCR7 in normal cells is low. Recently, many studies have suggested that CXCR7 promotes cell growth and metastasis in more than 20 human malignancies, among which lung cancer is the leading cause of cancer-associated deaths worldwide. Thus, the mechanism of CXCR7 in the progression of lung cancer is urgently needed. Methods First, we explored CXCR4 and CXCR7 expression in human lung cancer specimens and cell lines by immunohistochemistry, western blot and flow cytometry. Then, we chose the human lung adenocarcinoma cell line A549 that stably overexpressed CXCR7 through the way of lentivirus-mediated transduction. Next, “wound healing” assay and transwell assay were applied to compare the cell migration and invasion ability, and stripe assay was used to evaluate the cell polarization. Last, our team established a mouse xenograft model of human lung cancer and monitored tumor proliferation and metastasis by firefly luciferase bioluminescence imaging in SCID/Beige mice. Results In clinical lung cancer samples, CXCR7 expression was almost not detected in normal tissue but upregulated in lung tumor tissue, whereas, CXCR4 was highly expressed in both normal and tumor tissues. Furthermore, overexpression of CXCR7 enhanced A549 cell migration and polarization in vitro. Besides, mouse xenograft model of human lung cancer showed that CXCR7 promoted primary lung tumor’s growth and metastasis to the second organ, such as liver or bone marrow in SCID/Beige mice in vivo. Conclusions This study describes the multiple functions of CXCR7 in lung cancer. Thus, these results suggest that CXCR7 may be a malignancy marker and may provide a novel target for anticancer therapy.

High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.

Overexpression of CXCR7 Enhances Metastasis on Lung Cancer Cell

Chemokine receptor 7 induces metastasis of NSCLC via upregulating MMP-9 expression]

Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells

CCL25 Promotes the Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating VEGF and MMPs in a CCR9-dependent Manner.

CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck

XCR1 Promotes Cell Growth and Migration and is Correlated with Bone Metastasis in Non-Small Cell Lung Cancer.

Ccr9 Promotes Migration And Invasion Of Lung Adenocarcinoma Cancer Stem Cells

A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis

Crucial Biological Functions of CCL7 in Cancer

Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells

CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer

CTHRC1 Induces Non-Small Cell Lung Cancer (NSCLC) Invasion Through Upregulating MMP-7/MMP-9

Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells Through the CCR7–CCL21 Axis Modulated by TNF-α

Upregulation of the Chemokine Receptor CCR7 Expression by HIF-1αand HIF-2α in Non-Small Cell Lung Cancer

Expression of Molecular Factors Correlated with Metastasis in Small Cell Lung Cancer and Their Significance

Tumor-associated Macrophages Derived CCL18 Promotes Metastasis in Squamous Cell Carcinoma of the Head and Neck

CXCL5 Regulation of Proliferation and Migration in Human Non-Small Cell Lung Cancer Cells

CCL2 promotes metastasis and epithelial–mesenchymal transition of non‐small cell lung cancer via PI3K/Akt/mTOR and autophagy pathways

CCR7 Promote Lymph Node Metastasis Via Regulating VEGF-C/D-R3 Pathway in Lung Adenocarcinoma

Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways